Study of Highly Sensitive C-Reactive Protein in Type 2 Diabetes Mellitus and Prediction of Cardiovascular Risk With Glycemic Status

International Journal of Advances in Medicine
doi 10.18203/2349-3933.ijam20191472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

Study of High-Sensitivity C-Reactive Protein Levels in Subjects With Type 2 Diabetes Mellitus

International Journal of Clinical Biochemistry and Research
2018English

Study of Association of C - Reactive Protein and Alkaline Phosphatase in Type 2 Diabetes Mellitus Patients

Scholars International Journal of Biochemistry
2020English

Associations Among Glycemic Excursions, Glycated Hemoglobin and High-Sensitivity C-Reactive Protein in Patients With Poorly Controlled Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

A Study of Glycemic Status and Parasympathetic Functions in Nondiabetic Offsprings of Type 2 Diabetes Mellitus

International Journal of Biomedical and Advance Research
2013English

Exposing the Causal Effect of C-Reactive Protein on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study

Frontiers in Genetics
GeneticsMolecular Medicine
2018English

C – Reactive Protein as an Indicator for Complications in Type -2 Diabetes Mellitus

Indian Journal of Basic and Applied Medical Research
2020English

Effect of Legumes as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus

Archives of Internal Medicine
2012English

Early Prediction of Nephropathy and Cardiovascular Diseases in Indian Patients With Type 2 Diabetes Mellitus

International Journal of Medical Science and Public Health
2014English

Glycemic Control in Type 2 Diabetes Mellitus Patients

Chattagram Maa-O-Shishu Hospital Medical College Journal
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy